PortfoliosLab logo
NTLA vs. SE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NTLA and SE is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

NTLA vs. SE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intellia Therapeutics, Inc. (NTLA) and Sea Limited (SE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

NTLA:

-0.89

SE:

3.19

Sortino Ratio

NTLA:

-1.49

SE:

3.47

Omega Ratio

NTLA:

0.83

SE:

1.47

Calmar Ratio

NTLA:

-0.72

SE:

1.56

Martin Ratio

NTLA:

-1.44

SE:

15.88

Ulcer Index

NTLA:

48.55%

SE:

8.21%

Daily Std Dev

NTLA:

77.51%

SE:

44.03%

Max Drawdown

NTLA:

-96.45%

SE:

-90.51%

Current Drawdown

NTLA:

-96.11%

SE:

-56.30%

Fundamentals

Market Cap

NTLA:

$711.62M

SE:

$95.44B

EPS

NTLA:

-$5.23

SE:

$1.43

PEG Ratio

NTLA:

-0.10

SE:

1.00

PS Ratio

NTLA:

15.62

SE:

5.32

PB Ratio

NTLA:

0.91

SE:

10.65

Total Revenue (TTM)

NTLA:

$45.57M

SE:

$18.03B

Gross Profit (TTM)

NTLA:

$40.40M

SE:

$7.85B

EBITDA (TTM)

NTLA:

-$530.80M

SE:

$1.28B

Returns By Period

In the year-to-date period, NTLA achieves a -41.08% return, which is significantly lower than SE's 51.15% return.


NTLA

YTD

-41.08%

1M

-20.49%

6M

-56.02%

1Y

-67.87%

3Y*

-47.00%

5Y*

-17.07%

10Y*

N/A

SE

YTD

51.15%

1M

16.79%

6M

40.92%

1Y

137.51%

3Y*

24.72%

5Y*

14.98%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Intellia Therapeutics, Inc.

Sea Limited

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

NTLA vs. SE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NTLA
The Risk-Adjusted Performance Rank of NTLA is 77
Overall Rank
The Sharpe Ratio Rank of NTLA is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of NTLA is 55
Sortino Ratio Rank
The Omega Ratio Rank of NTLA is 88
Omega Ratio Rank
The Calmar Ratio Rank of NTLA is 77
Calmar Ratio Rank
The Martin Ratio Rank of NTLA is 77
Martin Ratio Rank

SE
The Risk-Adjusted Performance Rank of SE is 9696
Overall Rank
The Sharpe Ratio Rank of SE is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of SE is 9696
Sortino Ratio Rank
The Omega Ratio Rank of SE is 9696
Omega Ratio Rank
The Calmar Ratio Rank of SE is 8989
Calmar Ratio Rank
The Martin Ratio Rank of SE is 9898
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NTLA vs. SE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Intellia Therapeutics, Inc. (NTLA) and Sea Limited (SE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current NTLA Sharpe Ratio is -0.89, which is lower than the SE Sharpe Ratio of 3.19. The chart below compares the historical Sharpe Ratios of NTLA and SE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

NTLA vs. SE - Dividend Comparison

Neither NTLA nor SE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NTLA vs. SE - Drawdown Comparison

The maximum NTLA drawdown since its inception was -96.45%, which is greater than SE's maximum drawdown of -90.51%. Use the drawdown chart below to compare losses from any high point for NTLA and SE.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

NTLA vs. SE - Volatility Comparison

Intellia Therapeutics, Inc. (NTLA) has a higher volatility of 38.04% compared to Sea Limited (SE) at 12.39%. This indicates that NTLA's price experiences larger fluctuations and is considered to be riskier than SE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

NTLA vs. SE - Financials Comparison

This section allows you to compare key financial metrics between Intellia Therapeutics, Inc. and Sea Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20212022202320242025
16.63M
4.95B
(NTLA) Total Revenue
(SE) Total Revenue
Values in USD except per share items